Categories: News

Cheelcare Turns Heads at the Canadian Seating and Mobility Conference in Toronto

Toronto, Ontario–(Newsfile Corp. – September 11, 2025) – Cheelcare Inc. (TSXV: CHER) (“Cheelcare” or the “Company”), a Canadian leader in assistive mobility devices, turned heads at the 2025 Canadian Seating and Mobility Conference (CSMC), one of Canada’s premier gatherings for rehabilitation professionals, clinicians, and mobility industry leaders.

Providers try Curio at Cheelcare’s booth at the 2025 CSMC

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/11847/265899_csmc1.jpg

Cheelcare presented its latest updates to the Companion power-assist system alongside the company’s newest innovation, Curio – Cheelcare’s complex rehab power wheelchair built on their patented robotic platform. Both devices are designed to provide wheelchair users with enhanced quality of life and independence.

Cheelcare’s Sales Representative for Ontario Demonstrates Newest Companion Product Updates at 2025 CSMC

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/11847/265899_csmc2.jpg

“CSMC is Canada’s largest event for our industry and allows us to directly connect with the clinicians, providers, and assistive technology professionals who are on the front lines of mobility care,” said Allan Boyd, Cheelcare’s VP of Growth. “The response to both Companion and Curio has been very positive and highlights the demand for more innovative solutions in the mobility market.”

About Cheelcare Inc.
Cheelcare designs and manufactures innovative mobility solutions that empower independence for people with disabilities. From the Companion power assist devices to the groundbreaking Curio robotic wheelchair, Cheelcare combines engineering excellence with human-centered design to improve quality of life.

For more information, please visit: www.cheelcare.ca.

For further information, please contact:
Allex Laurin, Director of Marketing
Cheelcare Inc.
Tel: 1-888-948-2680 x200
Email: alaurin@cheelcare.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/265899

Staff

Recent Posts

Predictmedix AI Announces Closing of Final Tranche of Non-Brokered Private Placement

Toronto, Ontario--(Newsfile Corp. - December 5, 2025) - Predictmedix AI Inc. (CSE: PMED) (OTC Pink:…

2 hours ago

Techficient Launches Surefire, Its Proprietary Modern Underwriting Engine

BOISE, Idaho, Dec. 5, 2025 /PRNewswire/ -- Techficient, a leading innovator in Insurtech solutions, announces the…

2 hours ago

Clinical Education Alliance Becomes Decera Clinical, Delivering Education, Insights, and Communications

Company brings its Scientific Activation™ mission to life at ASH Annual Meeting following November rebrand RESTON,…

2 hours ago

Shrub Oak International School Reinforces Unwavering Commitment to Student Safety and Security

MOHEGAN LAKE, N.Y., Dec. 5, 2025 /PRNewswire/ -- Shrub Oak International School today announced enhanced…

2 hours ago

‘I’D RATHER GET A ROOT CANAL’: US WORKERS DREAD THE OFFICE HOLIDAY PARTY

National poll reveals 27% of workers prefer dental work over office celebrations as workplace disconnection…

2 hours ago

Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement

Maxim Group LLC is acting as the exclusive Financial Advisor for the transaction PHILADELPHIA, PA…

2 hours ago